IMR Press / CEOG / Volume 24 / Issue 3 / pii/1997042

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Anticardiolipin antibodies in pre-eclampsia and intrauterine growth retardation

Show Less
1 Institute of Gynecology, University of Messina (Italy)
Clin. Exp. Obstet. Gynecol. 1997, 24(3), 135–137;
Published: 10 September 1997
Abstract

Objective: to establish an association of anticardiolipin antibody (ACA) levels and pre-eclampsia or intrauterine growth retarda­tion (IUGR). Methods: twenty-eight patients with pre-eclampsia, 28 with IUGR and 28 normotensive control group were matched for maternal age, race, weight, cigarette smoking, and parity. All had plasma anticardiolipin antibodies (GPL and MPL) detected by the mod卜 fled enzyme- linked immuno-absorbent assay (ELISA) technique. Results: no statistical significant difference in ACA values, both GPL and MPL, was found among the three groups studied. Furthermore, none reached a value of ACA that could be considered clinically relevant (>15). Conclusion: no association was found in anticardiolipin antibody levels between pre-eclamptic and IUGR versus the control group.

Keywords
Anticardiolipin antibodies
Pre-eclampsia
IUGR
Share
Back to top